TG Therapeutics, Inc. (TGTX) is a publicly traded Healthcare sector company. As of May 21, 2026, TGTX trades at $39.59 with a market cap of $6.04B and a P/E ratio of 12.32. TGTX moved +0.84% today. Year to date, TGTX is +32.98%; over the trailing twelve months it is +12.09%. Its 52-week range spans $21.16 to $46.48. Analyst consensus is neutral with an average price target of $44.25. Rallies surfaces TGTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading TGTX stock inside the company?
Recent TGTX insider activity includes Echelard Yann sold 5.00K, Lonial Sagar sold 20.85K, Echelard Yann sold 10.00K, Power Sean A sold 10.02K, and Power Sean A sold 11.34K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
TGTX Key Metrics
Key financial metrics for TGTX
Metric
Value
Price
$39.59
Market Cap
$6.04B
P/E Ratio
12.32
EPS
$3.22
Dividend Yield
0.00%
52-Week High
$46.48
52-Week Low
$21.16
Volume
4.80K
Avg Volume
0
Revenue (TTM)
$700.35M
Net Income
$461.90M
Gross Margin
83.05%
Recent TGTX Insider Trades
Echelard Yann sold 5.00K (~$162.85K) on Nov 24, 2025.
Lonial Sagar sold 20.85K (~$672.27K) on Sep 11, 2025.
Echelard Yann sold 10.00K (~$369.40K) on Jun 13, 2025.
Power Sean A sold 10.02K (~$285.94K) on Jan 6, 2025.
Power Sean A sold 11.34K (~$343.44K) on Jan 3, 2025.
Recent TGTX insider activity includes Echelard Yann sold 5.00K, Lonial Sagar sold 20.85K, Echelard Yann sold 10.00K, Power Sean A sold 10.02K, and Power Sean A sold 11.34K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TGTX?
Yes. Rallies tracks TGTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TGTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TGTX. It does not provide personalized investment advice.
